Fundraising Fox

Poul Sørensen

Partner & EIR at Argobiostudio · CSO at Allerotherapeutics

Paris, France

Writes $100K – $5M checks · typically $1.5M

Find your path to Poul

376 people in our graph share verified history with Poul — schools, employers, funds. One of them is your warm intro.

Jesper GromadaunlockedPoul: together at University of Copenhagen (1992–1994)
×6Poul: together at University of Copenhagen
×4Poul: together at Pharmacia & Upjohn
Poul: together at Maxygen, Inc

About

Poul Sørensen is CEO and Executive Chairman of Inverna Therapeutics. He holds a PhD in Biochemistry from Copenhagen University and serves as an Honorary Professor at Aarhus University. Sørensen has co-founded multiple biotechnology companies and has held leadership roles in company building, R&D, corporate strategy, and business development, with focus areas including neurology and inflammation and immunology.

Partner & EIR at Argobiostudio

Intro paths

→

In turn, Poul can intro founders to Argobiostudio's investors below.

Argobiostudio's investors · 3

Angelini VenturesRomeBpifranceParis, Ile-De-France · $270K checksKurma PartnersParis · $162K – $10.8M checks

CSO at Allerotherapeutics

Intro paths

→

In turn, Poul can intro founders to Allerotherapeutics's investors below.

Allerotherapeutics's investors · 1

Curie CapitalAmsterdam

Experience

  1. Inverna TherapeuticsCEO and Executive Chairmancurrent2024 — presentOdense, Denmark
  2. Argobio StudioPartner and Entrepreneur-in-Residencecurrent2022 — presentParis, France
  3. CenexumCo-founder and Board Membercurrent2022 — presentCopenhagen, Capital Region of Denmark, Denmark
  4. Allero TherapeuticsCo-founder & Chief Scientific Officercurrent2016 — presentRotterdam, Netherlands
  5. Aarhus UniversityHonorary Professor of Biomedicinecurrent2015 — presentAarhus, Denmark
  6. Ventac PartnersPartner2018 — 2022Paris, France
  7. Medday PharmaceuticalsGlobal Head of Corporate Strategy & Business Development2019 — 2020Paris, France
  8. Stallergenes GreerSenior Vice President, Global Head of Strategic Development2012 — 2017Greater Paris Metropolitan Region
  9. ALK AbellóVice President, Global Research2008 — 2012Hørsholm, Denmark.
  10. Biotech Research & Innovation Centre (BRIC), University of CopenhagenMember Board Of Directors2005 — 2011Copenhagen, Denmark
  11. LEO PharmaResearch Director2005 — 2008Ballerup, Denmark
  12. Micromet AGVice President, Head of Antibody Therapeutics Business Unit2003 — 2004Munich, Germany
  13. Maxygen, IncDirector, Biopharmaceutical Project Portfolio2001 — 2003Hørsholm, Denmark
  14. Active Biotech Research ABHead of Biology1998 — 2001Kalmar County, Sweden
  15. Pharmacia & UpjohnScientific Project Leader1994 — 1998Kalmar County, Sweden
  16. Carlsberg LaboratoryResearch associate/PhD student1989 — 1994Copenhagen, Denmark

Skills & more

R&D35Research14Biopharmaceuticals57Biotechnology90Drug Discovery88Pharmaceuticals1Molecular Biology24Immunology68Antibody engineeringInnovation Management3Inflammation12Allergy3
+12 morePsoriasisDermatologyAntibodiesBiomarkersTranslational MedicineVaccinesProject Portfolio ManagementPharmacologyStrategic PlanningAutoimmuneStrategyPharmaceutical Industry

Languages Danish · English · French · Germany · Swedish

From Poul's professional profile.

Frequently asked questions

Who is Poul Sørensen?
Poul Sørensen is CEO and Executive Chairman of Inverna Therapeutics. He holds a PhD in Biochemistry from Copenhagen University and serves as an Honorary Professor at Aarhus University. Sørensen has co-founded multiple biotechnology companies and has held leadership roles in company building, R&D, corporate strategy, and business development, with focus areas including neurology and inflammation and immunology.
Where does Poul Sørensen work?
Poul Sørensen is Partner & EIR at Argobiostudio and CSO at Allerotherapeutics.
What check size does Poul Sørensen write?
Poul Sørensen typically writes checks of $100K – $5M.
Where did Poul Sørensen go to school?
Poul Sørensen studied at University of Copenhagen (Ph.D, Biochemistry); University of Aarhus (M.Sc, Molecular Genetics).

Same school

Also attended University of Copenhagen212

David HelgasonUnity co-founder; Partner at TransitionJesper GromadaInvestor at Third Rock VenturesUlrik B. NielsenGeneral Partner at Mission BiocapitalTommy AhlersFormer Danish Science Minister at Giant Ventures Global LlpTaro HizumeGeneral Partner at Ff Venture CapitalClaus AnderssonGeneral Partner at Sunstone Capital

+ 206 more

Also attended University of Aarhus126

Merete Lundbye MøllerVenture Partner, General Counsel at Sunstone CapitalLars AndersenGeneral Partner at SEED Capital DenmarkJakob Fuglede NielsenCFO, Partner at SEED Capital DenmarkFernanda BartelsInvestor at Extantia CapitalCasper B. JohansenCo-founder & Partner, Co-Head of Spartan Advisory at The Spartan GroupMia GrosenVenture Partner at SuperSeed

+ 120 more

Shared employers

Also worked at Allero Therapeutics3

Mariette van der VeldenPartner at Curie CapitalCillian KingManaging Director at EQT Life SciencesSteven GlazerPartner at Ventac Partners

Also worked at ALK Abelló4

Bertil LindmarkVenture Partner at XGEN VentureFlemming PedersenCFO at Better CollectiveSusanna DahlgrenChief Operating Officer at OncorenaDenis DelvalPresident & CEO at Ethypharm

Also worked at LEO Pharma11

Alexi AndradeChief of Staff at Hi VenturesTaruho KurodaImpact Partner at Fresco CapitalVickie LaurentRegulatory Advisor at 2Flo VenturesDaniel RamirezFounding Partner at Ten VCChristian HedegaardPartner at Nordic CapitalTine KühnelFounder at Complir

+ 5 more

Also worked at Maxygen, Inc9

Jamie BacherEntrepreneur-In-Residence at The Innovation SpaceRuchita SinhaGeneral Partner at AV8 VenturesJosh SilvermanInvestor at Baruch Future VenturesGjalt HuismanInvestor at Baruch Future VenturesJan Møller MikkelsenPresident at Ascendis Pharma A/SFrances H. ArnoldVenture Partner at Catalio Capital Management, LP

+ 3 more